Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 15,200

Document Document Title
WO/2021/020481A1
The present invention is a method for producing an intermediate of iguratimod derivatives, a method for producing iguratimod, iguratimod having a novel crystal structure, and a method for producing the same. The present invention can rai...  
WO/2021/021632A1
The present disclosure relates to the preparation of synthetic cannabinol and homologs thereof having the structure of Formula (I), wherein, n is 1, 2, 3 or 4. The methods described herein provide for high yields and purity in a one-pot ...  
WO/2021/016717A1
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a mixing vessel, a volatizing unit, and a distillation unit. The mixing vessel combines a first in...  
WO/2021/016720A1
The present technology generally relates to a triploid Cannabis plant, triploid Cannabis seeds and to methods for generating such triploid Cannabis plant. The methods comprise crossing a tetraploid Cannabis plant with a diploid Cannabis ...  
WO/2021/018965A1
The present invention concerns compounds useful as modulators of sirtuins, in particular as SIRT1 activators. Moreover, the invention refers to the medical use of these compounds, in particular in the prevention and/or treatment of SIRT1...  
WO/2021/016716A1
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a first reaction vessel, a volatizing unit, and a distillation unit. The first reaction vessel pro...  
WO/2021/020788A2
The present invention relates to a method for synthesizing a 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative. When the method is used, a 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative can be effec...  
WO/2021/016718A1
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a volatizing unit, a fractional distillation unit, and a condensing unit. The volatizing unit rece...  
WO/2021/016280A1
The present disclosure provides certain tricyclic compounds that are Hypoxia Inducible Factor 2α (HIF-2α) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of HIF-2α. Also provided are pharmaceu...  
WO/2021/014229A1
The present invention relates to a compound of formula (I) or an enantiomer, to a pharmaceutically acceptable salt or solvate of this compound, or to a mixture thereof, wherein the core A, the substituents Z, Y and R1i are as defined in ...  
WO/2021/013931A1
The present invention relates to methods and means for inhibiting or preventing the growth of non-filamentous biofilm forming fungal cells with at least one flavone of formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are independently f...  
WO/2021/013278A1
The invention relates to a process for preparing a coumarin-caged forskolin derivative, to the forskolin derivative as such and to the use of the forskolin derivative.  
WO/2021/012046A1
There are provided compositions comprising at least one compound chosenfrom compound of formula (I), compound of formula (II), compound of formula (III) and compound of formula (IV) and a cannabinoid extract.  
WO/2021/009026A1
Compounds of formula (I): (Formula (I)) Formula (I) encompasses e.g. tetraline, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1H-isobenzofurane and indane derivatives. The compounds of formula (I) are useful as a pesticides,...  
WO/2021/008170A1
The present application provides a flavone derivative, a preparation method therefor, an application thereof, and a skin whitening product comprising same. The flavone derivative is a compound having a structure represented by formula I ...  
WO/2021/009229A1
The present invention relates to compounds of Formula (I), (I) wherein R1, R2, R3,W, Y, Z & G are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I), to their use for cont...  
WO/2021/001128A1
The present invention relates to compounds that inhibit expression of Id1 and/or Id3, as well as uses thereof in the treatment of cancer and other diseases and conditions associated with Id1 and/or Id3 expression.  
WO/2020/258014A1
Disclosed is a coumarin (ketone) oxime ester compound represented by formula (I) comprising the following formula (I-1) structural fragment, wherein X, A 1, A 2, A 3, A 4, R 3, R 4, R 5, R 6, R 8, R 9, R 10 and n are as defined in the sp...  
WO/2020/261021A1
Described are polymerizable fused tricyclic compounds of formula I: wherein R1, R2, R3, m, n, t, and rings B, C, and D are as defined herein. The compounds absorb various wavelengths of ultraviolet and/or visible light (such as high ener...  
WO/2020/262259A1
A method for peptide compound production which includes a step in which a compound represented by formula (1) is used; a reagent for protective-group formation which includes the compound; and the compound. At least one of R1 to R8 and Y...  
WO/2020/263975A1
This disclosure provides multifunctional conjugate molecules in which at least one β-lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic b...  
WO/2020/261299A1
The present invention relates to a cost-effective and eco-friendly technique of producing nuclear staining composition from Indian black berry fruit. The composition is as effective as its counterpart Hematoxylin in staining biological s...  
WO/2020/259565A1
Disclosed is an industrializable method for rapidly and efficiently extracting xanthophyll and quercetagetin, comprising the following steps: 1) extracting particles of marigold flower with a solution of acetone having a volume fraction ...  
WO/2020/261961A1
The present invention provides a chromene compound which can exhibit excellent photochromic properties. The chromene compound of the present invention is represented by formula (1). In the formula, at least one of R1 and R2 represents a ...  
WO/2020/252588A1
Grafted cannabis plants and related methods for producing a grafted cannabis plant are provided. In some embodiments, a scion is provided from a first cannabis plant having at least one of a first desired phenotype and a first desired ge...  
WO/2020/255156A1
The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein X, R1, R2, R3, R4, R5, R6, m and n are as defined in the detailed description. The present invention als...  
WO/2020/248060A1
Disclosed herein is a method for converting cannabidiol (CBD) into a composition comprising Δ9-tetrahydrocannabinol (Δ9-THC) and Δ8-tetrahydrocannabinol (Δ8-THC) in which the composition has a Δ9-ΤΗC:Δ8-ΤΗC ratio of greater tha...  
WO/2020/248058A1
Disclosed herein a method for converting (cannabidiol) CBD into a composition comprising Δ8-tetrahydrocannabinol (A8-THC) and Δ9-tetrahydrocannabinol (Δ9-THC), in which the composition has a Δ8-THC:Δ9-THC ratio that is greater than ...  
WO/2020/248057A1
Disclosed is a method for converting a first cannabinoid into a second cannabinoid that is a regioisomer of the first cannabinoid. The method comprises contacting the first cannabinoid with a Lewis-acidic heterogeneous reagent under reac...  
WO/2020/248062A1
Disclosed herein is a method for converting a first cannabinoid into a composition comprising a second cannabinoid and a third cannabinoid, in which the second cannabinoid and the third cannabinoid are each isomers of the first cannabino...  
WO/2020/248071A1
A method and system for isolating trichomes from plant matter. The method and system are applied to biomass including trichomes bound to structural plant material. The biomass is combined with a solution including a chelating agent for l...  
WO/2020/248077A1
Disclosed are methods for separating, recovering, and purifying tetrahydrocannabinolic acid (THCA) salts from an organic solvent solution comprising a mixture of cannabinoids. The methods comprise solubilizing the mixture of cannabinoids...  
WO/2020/248059A1
Disclosed is a method for converting a first cannabinoid into a second cannabinoid that is a regioisomer of the first cannabinoid. The method comprising contacting the first cannabinoid with: (i) a base having a pKb that is less than a c...  
WO/2020/248923A1
Provided are a flavone derivative represented by formula I and a pharmaceutically acceptable salt, hydrate or solvate thereof. (I) In formula I, R1 is H, C1-4 alkyl, amino, or C1-4 acyl; R2 is isopentenyl or 2-hydroxy-isopentyl; R3 is H,...  
WO/2020/248061A1
Disclosed herein is a method for converting cannabidiol (CBD) into a composition comprising Δ9-tetrahydrocannabinol ( Δ9-THC) and Δ8-tetrahydrocannabinol ( Δ8-THC) in which the composition has a Δ9-ΤΗΟ: Δ8-ΤΗΟ ratio of greate...  
WO/2020/247599A1
1-Phenylacetyl-8-aminohexahydro-2H-pyrano[3,4-b]pyrazines of formula I are disclosed. The compounds are kappa ligands and are useful to treat drug dependency.  
WO/2020/245142A1
A compound according to formula (-)-(Id*), wherein the compound shows negative specific rotation values, and it's use as fragrance.  
WO/2020/243844A1
The present disclosure relates to a cannabinoid composition that has enhanced absorption rates or higher concentrations of the administered cannabinoid into the systemic circulation, the composition comprising at least one cannabinoid an...  
WO/2020/240710A1
This flavonoid glycoside degradation method comprises: a hydrothermal treatment step for degrading flavonoid glycosides into flavonoids by performing, in an autoclave, a hydrothermal treatment on a raw material solution containing flavon...  
WO/2020/241529A1
The present invention addresses the problem of providing a compound of high photobase generation efficiency. The present invention is a carbamoyl oxime compound represented by general formula (I). (In the formula, A represents an aroma...  
WO/2020/240705A1
This flavonoid glycoside degradation method comprises: a hydrothermal treatment step for degrading flavonoid glycosides into flavonoids by performing, in an autoclave, a hydrothermal treatment on a raw material solution containing flavon...  
WO/2020/232526A1
A process for producing THC-O-acetate using a succession of distillation, salting-out assisted liquid-liquid extractions (SALLEs), and solvent recovery techniques. Tetrahydrocannabinol (THC) in cannabis oil reacts with acetic anhydride u...  
WO/2020/232557A1
The present technology generally relates to methods of making cocoa butter-derived products that comprise cannabinoids. The present technology further generally relates to cocoa butter-derived products resulting from such methods.  
WO/2020/232530A1
There are provided compositions comprising a purified cannabidiol (CBD) or a derivative thereof and an anti-inflammatory botanical extract, and methods of use thereof for the management of pain in a subject.  
WO/2020/231870A1
A compound with the following general formula (I) and a general method for making this compound are provided, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15 and R16 are each independently selected from the group that in...  
WO/2020/227830A1
Methods for extracting one or more chemical compounds from cannabis plant material are provided. In some embodiments, the method may comprise: providing the cannabis plant material; extracting the cannabis plant material with a solvent t...  
WO/2020/228786A1
The present invention relates to the field of natural product extraction, and in particular relates to an industrialized method for rapidly and efficiently extracting xanthophyll and quercetagetin. The main improvement of the method lies...  
WO/2020/228513A1
The present invention relates to the field of biomedicine, and specifically comprises a series of derivatives of a novel CDK9 inhibitor having a benzopyran structure and use thereof. In view of the disadvantages of low anti-tumor activit...  
WO/2020/226972A1
The present disclosure provides Förster resonance energy transfer (FRET)-based probes for detecting copper, e.g., for detecting Cu(I) in live cells. The present disclosure provides methods for detecting copper, e.g., for detecting Cu(I)...  
WO/2020/223811A1
Pharmaceutical formulations are provided that include at least two antibiotically active ingredients: a cannabinoid that is one or more of cannabichromene (CBC), cannabidiol (CBD) and/or cannabigerol (CBG); a sesquiterpene that is one or...  

Matches 51 - 100 out of 15,200